Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro
Essi Parviainen, Sini Nurmenniemi, Sara Ravaioli, Sara Bravaccini, Aki Manninen, Arja Jukkola, Katri Selander · 2024
Read Human papillomavirus E6 alters Toll-like receptor 9 transcripts and chemotherapy responses in breast cancer cells in vitro by Essi Parviainen, Sini Nurmenniemi, Sara Ravaioli, Sara Bravaccini, Aki Manninen, Arja Jukkola, Katri Selander (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11625066.txt.
Description
Essi Parviainen and co-authors test whether a virus protein can mute a DNA sensor in breast cancer cells. The sensor, TLR9, reads loose DNA and helps rally defense. Low levels of it have been tied to worse outlook in one hard breast cancer type. Their 2024 study adds the HPV16 protein E6 to two breast cancer cell lines in the lab.
Under low oxygen, E6 cut the sensor's message levels in both lines. It also shifted how fast the cells grew. The treated cells grew harder to slow with standard chemotherapy drugs. In a small check of 37 tumor samples, no HPV gene trace turned up. The team reads the lab effect as real but the virus link in patients as still open.
Catalog record
| CREATOR | Essi Parviainen, Sini Nurmenniemi, Sara Ravaioli, Sara Bravaccini, Aki Manninen, Arja Jukkola, Katri Selander |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |